REFRACTORY ACUTE UNDIFFERENTIATED LEUKEMIA
Clinical trials for REFRACTORY ACUTE UNDIFFERENTIATED LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY ACUTE UNDIFFERENTIATED LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY ACUTE UNDIFFERENTIATED LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to beat relapsed blood cancers
Disease control Recruiting nowThis phase 1 trial tests giving a powerful chemotherapy combination (CLAG-M or FLAG-Ida) immediately followed by a reduced-intensity stem cell transplant for adults with myeloid cancers that have come back or not responded to treatment. The goal is to find the best dose of total …
Matched conditions: REFRACTORY ACUTE UNDIFFERENTIATED LEUKEMIA
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC
-
New combo attack on tough blood cancers: chemo plus transplant shows promise
Disease control Recruiting nowThis study tests a new approach for adults with aggressive blood cancers (like AML) that are likely to return after standard treatment. Participants receive a combination of chemotherapy drugs (decitabine plus FLAG-Ida) and low-dose radiation, followed immediately by a stem cell …
Matched conditions: REFRACTORY ACUTE UNDIFFERENTIATED LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC